Paper Details

  1. Home
  2. Paper Details

[Localised prostate cancer: the PREFERE trial].

Author: Bussar-MaatzRoswitha, StöckleMichael

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Prostate cancer is common in older men, but the death rate is low, with half of patients dying from other causes. Improved diagnosis and PSA screening have led to earlier detection, but these early stages have varied prognoses and require different treatments. This study will compare four treatment options for localized prostate cancer: surgery, radiation therapy, seed implants, and active surveillance. The study will allow patients to choose to not pursue one or two of these treatment options.
Paper Details　
Original Abstract of the Article :
Prostate cancer is the most common carcinoma of the elderly man and holds the third place in the ranking of cancer-specific mortality. However, mortality rates of 3 % are low, and half of the patients will die from intercurrent disease. Due to the significantly improved diagnostic methods and the in...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.zefq.2012.05.004

データ提供：米国国立医学図書館（NLM）

PREFERE Trial: A Landmark Study on Prostate Cancer Treatment

Prostate cancer is a prevalent disease, particularly among older men. While mortality rates have declined, the treatment options for localized prostate cancer remain a subject of debate. This article, published in Der Urologe, describes the PREFERE trial, a landmark study designed to compare the efficacy of different treatment approaches for localized prostate cancer.

A Prospective Randomized Multicenter Trial

The PREFERE trial is a prospective, randomized, multicenter study, which means that patients are randomly assigned to different treatment groups. This study will involve four treatment options that are currently recommended by German and European guidelines: radical prostatectomy, percutaneous radiotherapy, permanent seed implantation, and active surveillance. The study is expected to provide valuable data on the effectiveness of each treatment option, helping clinicians to make informed decisions about the best course of treatment for individual patients.

Improving Treatment for Prostate Cancer

The PREFERE trial represents a significant step forward in our understanding of prostate cancer treatment. By comparing different treatment options in a well-designed study, researchers aim to improve the quality of care for patients with localized prostate cancer. The results of this trial could potentially lead to more personalized treatment plans, tailored to the specific needs of each patient.

Dr. Camel's Conclusion

The PREFERE trial is an ambitious undertaking, reminiscent of a caravan navigating a vast desert with a clear destination in mind. Like the caravan, the researchers are on a journey to uncover the best path to conquer prostate cancer. The results of this trial hold immense promise for improving the lives of countless individuals, contributing to a brighter future for those affected by this disease.

Date :
  1. Date Completed 2012-11-13
  2. Date Revised 2012-07-23
Further Info :

Pubmed ID

22818151

DOI: Digital Object Identifier

10.1016/j.zefq.2012.05.004

Related Literature

Article Analysis
・Effective treatment of prostate cancer
SNS
PICO Info
in preparation
Languages

German

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.